Botulinum toxin type A for gummy smile
Anatomical targeting, protocol variability, and reproducible outcome measurement
DOI:
https://doi.org/10.67463/2pcxgv61Keywords:
botulinum toxin type A, excessive gingival display, Yonsei point, facial measurement, three-dimensional imaging, treatment reproducibilityAbstract
Background: Botulinum toxin type A (BoNT/A) can reduce excessive gingival display in selected muscular phenotypes, but the literature remains difficult to compare because anatomical assumptions, protocol reporting, and endpoint capture are uneven.
Objective: To critically reassess the use of BoNT/A for gummy smile, with emphasis on the Yonsei point, and to identify the variables that most strongly determine reproducible clinical response.
Methods: Structured critical narrative review integrating etiologic phenotyping, upper-lip elevator anatomy, BoNT/A formulation and preparation variables, clinical injection studies, and the measurement science underlying standardized photography and three-dimensional facial imaging.
Results: Current evidence supports temporary reduction of gingival display in selected muscular cases and provides a credible anatomical rationale for Yonsei-region targeting. However, the landmark is not universally transferable, and cross-study interpretation remains constrained by phenotype heterogeneity, incomplete reporting of dilution-volume-depth parameters, and weakly standardized photographic endpoints. Protocolized two-dimensional imaging can be reliable, whereas three-dimensional surface imaging generally provides lower geometric error when available. Longitudinal reading of Yonsei-derived publications suggests continuity of anatomical reasoning but slower progress in endpoint harmonization and formal reproducibility standards.
Conclusion: BoNT/A remains a defensible minimally invasive option for compatible muscular etiologies, but reproducible evidence depends on treating anatomy, product handling, injection mapping, and outcome capture as one protocol rather than as separate variables. The next substantive advance is standardized phenotyping linked to calibrated measurement, traceable documentation, and reproducible endpoint definition.
References
Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998;5(10):898-902. doi:10.1038/2338. DOI: https://doi.org/10.1038/2338 DOI: https://doi.org/10.1038/2338
Gregory KS, Acharya KR. A comprehensive structural analysis of Clostridium botulinum neurotoxin A cell-binding domain from different subtypes. Toxins (Basel). 2023;15(2):92. doi:10.3390/toxins15020092. DOI: https://doi.org/10.3390/toxins15020092 DOI: https://doi.org/10.3390/toxins15020092
Hada S, Lee JC, Lee EC, Ji S, Kim NA, Jeong SH, et al. Dissociation mechanics and stability of type A botulinum neurotoxin complex by means of biophysical evaluation. J Pharm Investig. 2022;52:453-63. doi:10.1007/s40005-022-00570-2. DOI: https://doi.org/10.1007/s40005-022-00570-2 DOI: https://doi.org/10.1007/s40005-022-00570-2
Ellis K, Thach T, Gallagher CJ. Biochemical stability and microbial control of reconstituted daxibotulinumtoxinA-lanm for injection. Toxins (Basel). 2023;15(12):683. doi:10.3390/toxins15120683. DOI: https://doi.org/10.3390/toxins15120683 DOI: https://doi.org/10.3390/toxins15120683
Polo M. Botulinum toxin type A in the treatment of excessive gingival display. Am J Orthod Dentofacial Orthop. 2005;127(2):214-8. doi:10.1016/j.ajodo.2004.09.013. DOI: https://doi.org/10.1016/j.ajodo.2004.09.013 DOI: https://doi.org/10.1016/j.ajodo.2004.09.013
Polo M. Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile). Am J Orthod Dentofacial Orthop. 2008;133(2):195-203. doi:10.1016/j.ajodo.2007.04.033. DOI: https://doi.org/10.1016/j.ajodo.2007.04.033 DOI: https://doi.org/10.1016/j.ajodo.2007.04.033
Mazzuco R, Hexsel D. Gummy smile and botulinum toxin: a new approach based on the gingival exposure area. J Am Acad Dermatol. 2010;63(6):1042-51. doi:10.1016/j.jaad.2009.09.043. DOI: https://doi.org/10.1016/j.jaad.2009.09.043 DOI: https://doi.org/10.1016/j.jaad.2010.02.053
Cengiz AF, Goymen M, Akcali C. Efficacy of botulinum toxin for treating a gummy smile. Am J Orthod Dentofacial Orthop. 2020;158(1):50-8. doi:10.1016/j.ajodo.2019.07.014. DOI: https://doi.org/10.1016/j.ajodo.2019.07.014 DOI: https://doi.org/10.1016/j.ajodo.2019.07.014
Costa AB, Romansina D, Ramalho J, Pereira P, Tedesco TK, Morimoto S, et al. Botulinum toxin A in the management of a gummy smile: a clinical controlled preliminary study. Aesthet Surg J. 2022;42(4):421-30. doi:10.1093/asj/sjab342. DOI: https://doi.org/10.1093/asj/sjab342 DOI: https://doi.org/10.1093/asj/sjab342
Chagas TF, Almeida NV, Lisboa CO, Ferreira DMTP, Mattos CT, Mucha JN. Duration of effectiveness of botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis. Braz Oral Res. 2018;32:e30. doi:10.1590/1807-3107bor-2018.vol32.0030. DOI: https://doi.org/10.1590/1807-3107bor-2018.vol32.0030 DOI: https://doi.org/10.1590/1807-3107bor-2018.vol32.0030
Zengiski ACS, Basso IB, Cavalcante-Leao BL, Stechman-Neto J, Santos RS, Guariza-Filho O, et al. Effect and longevity of botulinum toxin in the treatment of gummy smile: a meta-analysis and meta-regression. Clin Oral Investig. 2022;26(1):109-17. doi:10.1007/s00784-021-04223-w. DOI: https://doi.org/10.1007/s00784-021-04223-w DOI: https://doi.org/10.1007/s00784-021-04223-w
Rojo-Sanchis C, Montiel-Company JM, Tarazona-Alvarez B, Haas-Junior OL, Peiro-Guijarro MA, Paredes-Gallardo V, et al. Non-surgical management of the gingival smile with botulinum toxin A: a systematic review and meta-analysis. J Clin Med. 2023;12(4):1433. doi:10.3390/jcm12041433. DOI: https://doi.org/10.3390/jcm12041433 DOI: https://doi.org/10.3390/jcm12041433
Wang XY, Zou YR, Yuan MN, Huang HY, Han XF, Gong X. Dose and injection site of botulinum toxin type A for gummy smile management: a systematic review and bibliometric analysis. Toxicon. 2024;249:108058. doi:10.1016/j.toxicon.2024.108058. DOI: https://doi.org/10.1016/j.toxicon.2024.108058 DOI: https://doi.org/10.1016/j.toxicon.2024.108058
Hwang WS, Hur MS, Hu KS, Song WC, Koh KS, Baik HS, et al. Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod. 2009;79(1):70-7. doi:10.2319/021208-70.1. DOI: https://doi.org/10.2319/021208-70.1 DOI: https://doi.org/10.2319/091407-437.1
Duruel O, Ataman-Duruel ET, Tozum TF, Berker E. Ideal dose and injection site for gummy smile treatment with botulinum toxin-A: a systematic review and introduction of case study. Int J Periodontics Restorative Dent. 2019;39(4):e167-73. doi:10.11607/prd.3918. DOI: https://doi.org/10.11607/prd.3918 DOI: https://doi.org/10.11607/prd.3580
Al Wayli H. Versatility of botulinum toxin at the Yonsei point for the treatment of gummy smile. Int J Esthet Dent. 2019;14(1):86-95. PubMed: https://pubmed.ncbi.nlm.nih.gov/30714057/
Gupta D, Kohli S. The Yonsei point: a precision approach to gummy smile correction with botulinum neurotoxin. Indian Dermatol Online J. 2019;10(5):560-2. doi:10.4103/idoj.IDOJ_29_19. DOI: https://doi.org/10.4103/idoj.IDOJ_29_19 DOI: https://doi.org/10.4103/idoj.IDOJ_29_19
Booysen B, Baron RH, Uys A. Establishing standards for Yonsei point in a White South African population for the treatment of gummy smile. Clin Exp Dent Res. 2023;9(3):455-63. doi:10.1002/cre2.735. DOI: https://doi.org/10.1002/cre2.735 DOI: https://doi.org/10.1002/cre2.735
Gong X, Tang HN, Zhang AR, Wang Z, Tang ZH, Han XF, et al. Application of botulinum toxin at the Yonsei point for the treatment of gummy smile: a randomized controlled trial. Plast Reconstr Surg. 2024;153(4):711e-21e. doi:10.1097/PRS.0000000000010623. DOI: https://doi.org/10.1097/PRS.0000000000010623 DOI: https://doi.org/10.1097/PRS.0000000000010623
Picelli A, Tamburin S, Di Censo R, Smania N, Filippetti M. Does the diffusion profile differ between botulinum toxin type A formulations? Implications for the management of post-stroke spasticity. Toxins (Basel). 2024;16(11):480. doi:10.3390/toxins16110480. DOI: https://doi.org/10.3390/toxins16110480 DOI: https://doi.org/10.3390/toxins16110480
Gardner A, Sneller M, Tepp WH, Barbieri JT, Pellett S. Botulinum neurotoxin Light Chain/A1 uses fast synaptic vesicle cycling to cleave plasma membrane-bound SNAP-25. Commun Biol. 2025;8:1383. doi:10.1038/s42003-025-08633-4. DOI: https://doi.org/10.1038/s42003-025-08633-4 DOI: https://doi.org/10.1038/s42003-025-08633-4
Wan J, Yoon SE, Cartier H, Garson S, Yi KH. The Yonsei point: a precision approach to gummy smile correction with botulinum neurotoxin. J Craniofac Surg. 2025;36(7):e852-5. doi:10.1097/SCS.0000000000011253. DOI: https://doi.org/10.1097/SCS.0000000000011253 DOI: https://doi.org/10.1097/SCS.0000000000011253
Ayaz I, Shaheen E, Aly M, Shujaat S, Gallo G, Coucke W, et al. Accuracy and reliability of 2-dimensional photography versus 3-dimensional soft tissue imaging. Imaging Sci Dent. 2020;50(1):15-22. doi:10.5624/isd.2020.50.1.15. DOI: https://doi.org/10.5624/isd.2020.50.1.15 DOI: https://doi.org/10.5624/isd.2020.50.1.15
Gonçalves L, Silva D, Galdino K. Mapping botulinum toxin injection sites and automated unit totalization in orofacial harmonization: a session-based web module for standardized, traceable clinical imaging. Derecho y Cambio Social. 2026;23(88):1-19. doi:10.54899/dcs.v23i88.4842. DOI: https://doi.org/10.54899/dcs.v23i88.4842 DOI: https://doi.org/10.54899/dcs.v23i88.4842
Silva D, Gonçalves L, Galdino KS. Gummy smile modulation with onabotulinumtoxinA at the Yonsei point after aesthetic ceramic rehabilitation: a case report. Derecho y Cambio Social. 2026;23(87):1-16. doi:10.54899/dcs.v23i87.4768. DOI: https://doi.org/10.54899/dcs.v23i87.4768 DOI: https://doi.org/10.54899/dcs.v23i87.4768
Rho NK, Bae GY, Choi MS, Chung WK, Kim HY, Kim HM, et al. Consensus on the cosmetic use of a novel botulinum neurotoxin type A product (NEWLUX®) for facial expression muscles: 2024 guidelines and discussions by Korean experts. Toxins (Basel). 2025;17(2):61. doi:10.3390/toxins17020061. DOI: https://doi.org/10.3390/toxins17020061 DOI: https://doi.org/10.3390/toxins17020061
Myung Y, Woo K, Kim ST. Treatment of gummy smile using botulinum toxin: a review. J Dent Rehabil Appl Sci. 2021;37(2):61-72. doi:10.14368/jdras.2021.37.2.61. DOI: https://doi.org/10.14368/jdras.2021.37.2.61 DOI: https://doi.org/10.14368/jdras.2021.37.2.61
Published
Issue
Section
License
Copyright (c) 2026 Diego Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors retain copyright and grant the journal the right of first publication. This license permits use, distribution, reproduction, and adaptation in any medium, provided the original author and source are properly credited.
